The cardiovascular market research reports by iData cover Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management and the Electrophysiology market. The fastest growing segments within interventional cardiology are expected to be driven by new technologies, such as CTO crossers, FFR guidewires and OCT catheters. The vascular access market will grow due to a combination of increasing patient population and the shift towards technologically advanced devices that will continue to gain market share at the expense of older, less expensive devices. iData’s cardiovascular device market reports also include cardiac surgery, cardiac rhythm management, and other cardiovascular devices and procedures. Check out our different cardiovascular device market reports below.
By 2020, the global pacemaker market size was valued at $2.26 billion, with over 450,000 pacemaker procedures performed annually. The market size is expected to further increase over the forecast period and reach $2.6 billion in 2025. Throughout this medical market research, we analyzed global pacemaker companies across more than 70 countries and used our comprehensive methodology
By 2020, the global peripheral vascular device market size was valued at $11.9 billion, with over 16 million yearly peripheral vascular procedures performed. The market size is expected to increase at a compound annual growth rate (CAGR) of 5.2% to reach $16.9 billion in 2026. Throughout this medical market research, we analyzed 113 peripheral vascular
By 2020, the global vascular access device market size was valued at $4.2 billion, with around 1 billion vascular access devices placed each year. The market size is expected to increase over the forecast period and reach $4.8 billion in 2026. Throughout this medical market research, we analyzed 28 vascular access companies across more than 70
Industry Trends Heart failure affects over five million people annually in the U.S. alone and is the costliest cardiovascular illness, with upwards of $30 billion spent on managing heart failure each year. Cardiac rhythm management devices, such as pacemakers, ICDs and CRT devices, are implanted in patients with arrhythmias to correct cardiac pacing and/or to
Industry Trends There are a few components to the heart valve market, including tissue and mechanical non-percutaneous artificial heart valves. Of these two, tissue heart valves are generally preferred over mechanical valves, due to their higher levels of biocompatibility. Tissue valves, which are also known as bioprosthetic valves, are harvested from either human donors or
Industry Trends A major driver of growth in the cardiac surgery market is the aging population. As the population ages, the rate of heart failure will increase. In addition, the elderly is often not suitable for open heart surgery. The aging population also drives the growth of minimally invasive procedures, such as transcatheter heart valve